1
Market flat despite Teva’s losses Teva fell heavily following a US court ruling on Copaxone while Perrigo recorded the sharpest rise on the Tel Aviv 25 Index. By GLOBES, AVIV LEVY JULY 28, 2013 22:06 Teva 150 (photo credit: REUTERS/Ronen Zvulun) 1
